Familial adenomatous polyposis due to 5q22.2 microdeletion is an inherited condition that causes many growths called polyps in the colon and rectum, often starting in the teen years or early adulthood. Early symptoms of Familial adenomatous polyposis due to 5q22.2 microdeletion can include rectal bleeding, belly pain, diarrhea, or no symptoms at all until polyps are found. It may help to know that doctors have studied this condition for decades, and without treatment, Familial adenomatous polyposis due to 5q22.2 microdeletion carries a very high risk of colorectal cancer over time. The condition is lifelong, and some people also develop growths in the stomach or small intestine, so regular screening is a key part of care. Treatment for Familial adenomatous polyposis due to 5q22.2 microdeletion usually includes frequent colon checks, removal of polyps when possible, and often surgery to lower cancer risk.
How many people live with Familial adenomatous polyposis due to 5q22.2 microdeletion?
Familial adenomatous polyposis overall is listed by Orphanet at about 1 to 9 people per 100,000, which works out to roughly 81,000 to 729,000 people worldwide and about 3,400 to 30,000 people in the United States using current population totals (Orphanet, 2024; United Nations, 2024; U.S. Census Bureau, 2024). This 5q22.2 microdeletion form is only a subset of that group, and because larger missing pieces affecting the APC gene are estimated to explain about 8% to 12% of APC-related polyposis, a rough estimate would be about 6,000 to 87,000 people worldwide and about 270 to 3,600 in the United States, but this is an estimate rather than a direct count (GeneReviews, 2023).
Overview
Familial adenomatous polyposis due to 5q22.2 microdeletionSymptoms
Familial adenomatous polyposis due to 5q22.2 microdeletion often causes no early symptoms. As many colon polyps appear, often in the teens, people may notice rectal bleeding, belly pain, diarrhea, or constipation. Some also have dental, eye, or growth-related features.
Outlook and prognosis
With familial adenomatous polyposis due to 5q22.2 microdeletion, outlook depends on early and lifelong bowel checks, because many develop hundreds of colon polyps in the teens and have a very high colorectal cancer risk without treatment. With planned surveillance and, when needed, surgery, many people live well into adulthood.
Causes and risk factors
Familial adenomatous polyposis due to 5q22.2 microdeletion is caused by a missing piece of chromosome 5 that includes the APC gene. It can be inherited from a parent or happen new in early development. Family history is the main risk factor.
Genetic influences
Genetics are central to Familial adenomatous polyposis due to 5q22.2 microdeletion, because it is caused by a missing stretch of chromosome 5 that includes APC. This genetic change usually runs in families, though it can also happen for the first time in a child.
Diagnosis
Familial adenomatous polyposis due to 5q22.2 microdeletion is usually diagnosed from clinical features and colon imaging showing many polyps. The genetic diagnosis of familial adenomatous polyposis is confirmed with genetic tests that detect the 5q22.2 microdeletion.
Treatment and drugs
Familial adenomatous polyposis due to 5q22.2 microdeletion is managed with regular colon checks, removal of polyps when possible, and often surgery to lower bowel cancer risk. Many also need upper gut screening and, at times, medicines such as sulindac.
Symptoms
Familial adenomatous polyposis due to 5q22.2 microdeletion can affect daily life through repeated bowel checks, stomach or bowel symptoms, and sometimes learning or dental differences. Some of the early features of familial adenomatous polyposis due to 5q22.2 microdeletion can be easy to miss because many polyps cause no symptoms at first. The main feature is the development of many small growths, called polyps, in the colon and rectum, often starting in the teen years or young adulthood and raising cancer risk if not treated. Features vary from person to person, and some become more noticeable with age.
People with this condition often develop dozens to hundreds of polyps in the colon and rectum, usually during the teen years or early adulthood. These growths may not cause obvious problems at first, so they are often found on screening tests.
Blood on the stool, in the toilet, or on toilet paper can happen when polyps become irritated. Slow bleeding over time can also cause low iron, which may lead to tiredness or shortness of breath.
Some people with familial adenomatous polyposis due to 5q22.2 microdeletion have more frequent bowel movements, constipation, urgency, mucus, or cramping belly pain. What once felt effortless can start to require more energy or focus when bathroom trips become harder to predict.
Polyps can also grow in the stomach or the first part of the small intestine. Many people do not feel these, but some notice indigestion, nausea, or pain high in the belly.
How people usually first notice Familial adenomatous polyposis due to 5q22.2 microdeletion?
How familial adenomatous polyposis due to a 5q22.2 microdeletion is first noticed can vary, but many families first learn about it when a child has genetic testing because of developmental delay, autism or learning differences, or certain physical findings, rather than because of bowel symptoms. In others, the first signs of familial adenomatous polyposis due to a 5q22.2 microdeletion appear later, often in the teen years or early adulthood, when screening finds many colon polyps or when there is rectal bleeding, belly pain, diarrhea, or unexplained anemia. Doctors may also become suspicious if there is a strong family history of colon polyps or early colorectal cancer, because this condition greatly raises that risk over time.
Types of Familial adenomatous polyposis due to 5q22.2 microdeletion
No distinct types of Familial adenomatous polyposis due to 5q22.2 microdeletion are widely recognized.
Can I slow down the onset of symptoms?
Not really: for people living with familial adenomatous polyposis, or FAP, caused by a 5q22.2 microdeletion, there is no strong evidence that diet, exercise, supplements, or other lifestyle changes can meaningfully delay when colon polyps start to appear, because the condition is driven mainly by the inherited genetic change. Healthy habits like not smoking, staying active, and keeping up with routine care may help overall health and may lower some cancer risks, but that is not the same as preventing FAP or stopping polyp growth. What does clearly help is early and regular colon screening and, when needed, planned surgery to lower the risk of colorectal cancer; while this cannot stop the condition from starting, it can make a very big difference in staying well.
What genetics can tell you about symptoms
Yes. In familial adenomatous polyposis caused by a 5q22.2 microdeletion, the size and exact location of the missing DNA can influence symptoms, including how early colon polyps appear, how many develop, and whether there are features outside the colon such as developmental delay, learning difficulties, or other physical findings if nearby genes are also missing. Even so, symptoms can still vary quite a bit between people with similar deletions, so genetics helps estimate patterns and risks rather than predict exactly what any one person will experience.
Causes and risk factors
For many living with familial adenomatous polyposis due to 5q22.2 microdeletion, the risk starts at birth because a small piece of chromosome 5 is missing. That missing piece usually removes the APC gene, and sometimes nearby genes too. A family history of familial adenomatous polyposis due to 5q22.2 microdeletion is the main risk factor, although some children are the first in the family to have it. Age also matters because colon polyps often begin in the teen years and increase over time. Smoking, heavy alcohol use, extra body weight, and low activity do not cause the condition, but they may add to the already high risk of colorectal cancer.
What are the most common causes or risk factors?
The main cause of this condition is a small missing piece of genetic material on chromosome 5 that includes APC, a gene that normally helps control growth in the lining of the colon. In many families it is passed down from a parent, so having a parent or close relative with this condition, many colon polyps, or colon cancer at a young age is the biggest risk factor; in others, the genetic change happens for the first time in the child. It is not usually caused by diet, stress, or other everyday habits.
Environmental and biological risk factors
The environmental risk factors for familial adenomatous polyposis due to 5q22.2 microdeletion are not well defined. Doctors often group risks into internal (biological) and external (environmental), but for this specific condition the main known factor is a chromosome change that happens before birth, and strong outside triggers have not been clearly identified.
This condition is tied to a small missing piece of chromosome 5 that happens very early before birth. That early biological change is the main known factor linked to the condition occurring.
In many cases, the missing chromosome segment appears as a chance error in the egg, sperm, or earliest cell divisions after conception. For many living with familial adenomatous polyposis due to 5q22.2 microdeletion, this means there may be no clear outside reason it happened.
Older maternal or paternal age is linked with some chromosome conditions, but a clear and consistent link to this exact 5q22.2 microdeletion has not been established. In most families, age alone does not explain why it occurred.
Common health conditions during pregnancy have not been clearly shown to cause this specific microdeletion. When these conditions are present, they are reviewed as part of the medical history rather than treated as proven risk factors.
Genetic risk factors
For families facing repeated colon polyps or bowel cancer at a young age, the root problem in familial adenomatous polyposis due to 5q22.2 microdeletion is usually a missing stretch of chromosome 5. When doctors talk about the genetic causes of familial adenomatous polyposis due to 5q22.2 microdeletion, they are usually referring to deletion of the APC gene and sometimes nearby genes as well. Some risk factors are inherited through our genes. The change often runs in families, but it can also appear for the first time in someone with no known family history.
5q22.2 microdeletion: The main cause is a small missing piece of chromosome 5 in the 5q22.2 region. This missing segment removes one working copy of key genetic material that helps protect the bowel lining from abnormal growth.
APC gene loss: In most people, the deleted region includes the APC gene, which is the major gene linked to FAP. Without one working copy of APC, the risk of developing many adenomatous polyps and later colorectal cancer rises sharply.
Family inheritance: This condition is usually inherited in an autosomal dominant pattern, meaning one altered copy is enough to cause risk. If a parent has the microdeletion, each child has a 1 in 2, or 50%, chance of inheriting it.
New genetic change: Some people develop the microdeletion for the first time in their family, with no earlier relatives known to be affected. This is called a de novo change, and it can explain FAP even when family history seems negative.
Larger deletions: In some families, the missing segment is bigger and removes nearby genes along with APC. This can change how the condition shows up and may lead to extra health features beyond the bowel.
Lifestyle risk factors
Familial adenomatous polyposis due to 5q22.2 microdeletion is not caused by lifestyle, but daily habits can still influence bowel symptoms, recovery from treatment, and the chance of added complications over time. When discussing how lifestyle affects familial adenomatous polyposis due to 5q22.2 microdeletion, the focus is usually on protecting the digestive tract, supporting nutrition, and reducing avoidable strain on already vulnerable tissues. The most helpful habits often depend on whether a person still has their colon, has had colorectal surgery, or also has stomach or duodenal polyps.
Smoking does not cause this inherited condition, but it can worsen inflammation, impair healing after endoscopy or surgery, and raise concern for upper gastrointestinal and other cancer risks. Avoiding tobacco is especially important in people who already need lifelong surveillance for polyps and related tumors.
Heavy alcohol use can irritate the stomach and intestines, worsen dehydration or diarrhea, and make it harder to maintain good nutrition after colectomy or other bowel surgery. It may also complicate liver health and recovery if treatment is needed.
A diet high in processed meats, low in fiber tolerance, or poor in overall nutrient quality may aggravate bowel symptoms and make it harder to meet vitamin, mineral, and calorie needs. A well-planned eating pattern tailored to bowel function can support recovery, energy, and long-term gastrointestinal health.
Large, high-fat, or highly irritating meals can increase cramping, bloating, frequent stools, or urgency, especially after colorectal surgery. Smaller, more predictable meals and attention to individual food triggers may improve day-to-day symptom control.
Risk prevention
Familial adenomatous polyposis due to 5q22.2 microdeletion cannot usually be prevented, because it is caused by a genetic change present from birth. In day-to-day life, prevention is mainly about lowering the risk of bowel cancer and other complications through regular monitoring, planned treatment, and healthy habits. Many living with familial adenomatous polyposis due to 5q22.2 microdeletion feel well for years, so care often starts before symptoms appear. Prevention is flexible—it adapts to your life and health background.
Frequent bowel screening is one of the main ways to reduce cancer risk in familial adenomatous polyposis due to 5q22.2 microdeletion. These checks can find and remove polyps early, often before they turn into cancer.
When the number of polyps becomes too high, surgery to remove part or all of the large bowel may be the safest way to prevent colorectal cancer. The timing depends on polyp burden, age, and what doctors see on surveillance.
This condition can also cause growths in the stomach and first part of the small bowel, so regular upper endoscopy may help prevent serious complications. This is especially important because early symptoms of familial adenomatous polyposis due to 5q22.2 microdeletion may be absent or easy to miss.
Close relatives may benefit from genetic counseling and testing, because finding the condition early can allow cancer prevention to start sooner. In families with this condition, screening plans are often tailored by age and test results.
Can you prevent Familial adenomatous polyposis due to 5q22.2 microdeletion?
No. This condition cannot be prevented because it is caused by a missing piece of genetic material that is present from birth, whether it runs in the family or happens for the first time in a child. What can help is finding it early and following regular bowel checks and treatment, which can greatly lower the chance of serious problems, especially bowel cancer.
Transmission
Familial adenomatous polyposis due to 5q22.2 microdeletion is not contagious, so it cannot spread from one person to another through touch, sex, blood, food, or the air. Instead, how familial adenomatous polyposis due to 5q22.2 microdeletion is inherited depends on a missing piece of chromosome 5, often affecting the APC gene, being passed from parent to child.
Many living with this form of familial adenomatous polyposis have an affected parent, and each child of a parent who carries the deletion has a 1 in 2, or 50%, chance of inheriting it. Sometimes the deletion happens for the first time in a child, so there may be no earlier family history even though that child can still pass it on to their own children.
When to test your genes
Consider genetic testing if you have dozens to hundreds of colon polyps, colorectal cancer at a young age, or a close relative with familial adenomatous polyposis or an APC-region 5q22.2 microdeletion. If a family change is already known, testing is often offered in childhood because it guides colon screening and related care early.
Diagnosis
People with familial adenomatous polyposis due to 5q22.2 microdeletion are often diagnosed after many colon polyps are found, sometimes in the teen years or early adulthood, or when a strong family history raises concern. Doctors also look for related features outside the colon, because this condition can affect more than one part of the body. Getting a diagnosis is often a turning point toward answers and support. The diagnosis of familial adenomatous polyposis due to 5q22.2 microdeletion is usually confirmed with genetic testing.
Doctors ask about bowel symptoms, previous polyps, and any family history of colon cancer or polyposis. A detailed family and health history can help show whether the pattern suggests an inherited condition.
This exam lets doctors look directly at the lining of the colon and rectum for the many polyps that are typical of this condition. In many living with familial adenomatous polyposis due to 5q22.2 microdeletion, finding dozens to hundreds of adenomatous polyps is a major clue.
Doctors may also examine the stomach and first part of the small intestine because polyps can develop there too. These findings help show how much of the digestive tract is involved.
A blood test can look for a missing piece of chromosome 5 at 5q22.2, which usually includes the APC gene and sometimes nearby genes. This is the key test for the genetic diagnosis of familial adenomatous polyposis due to 5q22.2 microdeletion.
How is Familial adenomatous polyposis due to 5q22.2 microdeletion diagnosed?
Doctors usually diagnose this condition by looking at your personal and family history and by doing a colonoscopy, a test that lets them look inside the colon and rectum for the very large number of polyps that are typical of familial adenomatous polyposis. The diagnosis is then often confirmed with a blood test that looks for a small missing piece of chromosome 5, called a 5q22.2 microdeletion, which affects a gene that helps control polyp growth. Because this condition can also affect other parts of the body, doctors may check for related findings outside the bowel as well.
Stages of Familial adenomatous polyposis due to 5q22.2 microdeletion
Familial adenomatous polyposis due to 5q22.2 microdeletion does not have defined progression stages. This is because it is mainly a genetic condition identified by a very high tendency to develop colon and rectal polyps over time, rather than a disease with fixed step-by-step phases. Doctors usually start with a conversation about bowel symptoms, family history, and early symptoms of familial adenomatous polyposis due to 5q22.2 microdeletion, then use tests such as colonoscopy and genetic testing to confirm the diagnosis. Ongoing monitoring usually focuses on how many polyps are present, whether new growths are appearing, and screening for related problems in the digestive tract and other parts of the body.
Outlook and prognosis
The outlook for familial adenomatous polyposis due to 5q22.2 microdeletion is driven mainly by how early affected people enter surveillance and whether colon surgery is timed appropriately, because untreated colorectal cancer risk is extremely high and approaches nearly 100% over a lifetime. With modern management, including regular endoscopy, prophylactic colectomy when indicated, and monitoring for duodenal, thyroid, and desmoid disease, life expectancy can be substantially improved. Prognosis is more variable than in classic APC-related FAP alone because the 5q22.2 microdeletion may remove neighboring genes and can be associated with developmental delay, congenital anomalies, or other medical problems that also affect long-term outcomes. Mortality today is increasingly related not only to colorectal cancer but also to extracolonic complications such as duodenal or periampullary cancer and, in some patients, aggressive desmoid tumors. Children and adults who receive coordinated care from gastroenterology, surgery, genetics, and other specialists generally have the best outcomes. Because severity differs from person to person, prognosis should be individualized based on polyp burden, cancer history, associated features of the microdeletion, and access to lifelong surveillance.
Long-term effects
For many living with familial adenomatous polyposis due to 5q22.2 microdeletion, the biggest long-term concern is a very high lifetime risk of cancer in the colon and rectum, along with growths in other parts of the digestive tract. Because this microdeletion can remove more than one gene, some people also have features outside the gut, and the pattern can be broader than in classic familial adenomatous polyposis. Long-term effects vary widely, especially between childhood and adulthood, and depend in part on how much genetic material is missing.
Hundreds to thousands of colon and rectal polyps often build up over time, usually starting in the teenage years or young adulthood. If the bowel is left in place, colorectal cancer becomes very likely, which is why the long-term effects of familial adenomatous polyposis are taken so seriously.
Polyps can also grow in the stomach, duodenum, and the area where the bile duct enters the intestine. Over many years, some of these growths can turn into cancer, especially in the duodenum or ampulla.
Some people develop desmoid tumors, which are growths made of scar-like tissue rather than typical cancer cells. They can press on the bowel, blood vessels, or other organs and may cause pain, blockage, or other serious problems.
Familial adenomatous polyposis can raise the risk of several other cancers, including thyroid cancer and, in early childhood, hepatoblastoma, a rare liver cancer. These risks are much lower than the colorectal risk but are still part of the long-term picture.
How is it to live with Familial adenomatous polyposis due to 5q22.2 microdeletion?
Living with familial adenomatous polyposis due to a 5q22.2 microdeletion often means growing up with regular medical visits, repeated colon checks, and sometimes major decisions such as preventive surgery to lower the very high risk of colorectal cancer. Daily life can include managing bowel symptoms if polyps become numerous, keeping up with screening for other growths that can occur in the stomach or small intestine, and, in some families, coping with extra challenges if the deletion affects nearby genes as well. It can also affect the people around you, because close relatives may need genetic testing and ongoing screening, and families often carry both the practical load of appointments and the emotional weight of living with an inherited condition that can be serious but is far more manageable when it is found early.
Treatment and drugs
Familial adenomatous polyposis due to 5q22.2 microdeletion is usually treated by closely watching for growths in the colon and other parts of the digestive tract, removing them when possible, and planning surgery when the number of polyps becomes too high for safe control. Because this condition can strongly raise the risk of colorectal cancer, many people living with familial adenomatous polyposis eventually need surgery to remove the colon, often in the teens or young adulthood, although timing can vary from person to person. Doctors may also use regular upper endoscopy to check the stomach and small intestine, since polyps can develop there too, and they may monitor for other health problems linked to the deletion. Medicines do not cure familial adenomatous polyposis, but some drugs may help lower polyp growth in certain people; your doctor can help weigh the pros and cons of each option. Supportive care also matters, because keeping up with screening, surgery follow-up, and family genetic counseling can make treatment more manageable day to day.
Can you cure Familial adenomatous polyposis due to 5q22.2 microdeletion?
No, there is currently no cure for familial adenomatous polyposis caused by this chromosome change, because the underlying inherited gene problem cannot be reversed. Treatment focuses on preventing cancer and other problems by doing regular checks, removing growths when possible, and sometimes having surgery to remove the colon before cancer develops. Many people living with this condition can do well with close follow-up and timely treatment.
Non-drug treatment
Living with Familial adenomatous polyposis due to 5q22.2 microdeletion often means regular procedures and checkups, even when you feel well day to day. The main non-drug treatments aim to find and remove polyps early, lower cancer risk, and support digestion and recovery after surgery. Managing this condition often involves a team that may include a gastroenterologist, colorectal surgeon, genetics specialist, dietitian, and sometimes a psychologist.
Regular colonoscopy or sigmoidoscopy is a core part of care, because polyps can build up over time without causing symptoms at first. During these exams, some polyps may be removed, which can help reduce risk while planning longer-term treatment.
Many people with Familial adenomatous polyposis due to 5q22.2 microdeletion eventually need surgery to remove the colon, and sometimes the rectum, because the number of polyps becomes too high to manage safely with scopes alone. The timing depends on polyp burden, age, symptoms, and the early symptoms of familial adenomatous polyposis, such as bleeding, changes in bowel habits, or belly pain.
Polyps can also grow in the stomach and first part of the small intestine, so regular upper endoscopy is often recommended. These checks help doctors watch for changes and remove concerning growths when possible.
If surgery leaves the rectum in place or creates an internal pouch, that area still needs regular scope exams. Ongoing surveillance helps catch new polyps early, since risk does not fully disappear after surgery.
Your genes may have an impact on how drugs work for you
For people living with familial adenomatous polyposis caused by a small missing piece of chromosome 5, treatment is usually focused on finding and removing growths early, so there is not a well-established, routine gene-based way to choose everyday medicines just for this condition. If cancer develops, inherited differences in how the body breaks down some cancer drugs can sometimes affect how well those medicines work or how likely they are to cause side effects, but this is separate from the chromosome change that causes the condition itself. In practice, doctors usually base treatment on the number of growths, where they are, age, past surgery, and cancer history, and they may consider special drug testing only in certain cancer-treatment situations.
Pharmacological treatments
For people living with familial adenomatous polyposis due to 5q22.2 microdeletion, medicines do not remove the underlying genetic risk, and they do not replace regular screening or preventive surgery. Medication can feel like a big step, but some drugs may help lower the number or size of polyps for a time, or help treat related problems such as desmoid tumors. In practice, medicines for familial adenomatous polyposis are usually used as an add-on to endoscopy, surgery, and close follow-up.
Sulindac is a nonsteroidal anti-inflammatory drug, or NSAID, that can shrink some colon and rectal polyps in people with FAP. It may be used after surgery if polyps remain in the rectum, or in selected situations before surgery, but it does not reliably prevent cancer on its own.
Celecoxib is another NSAID that has been used to reduce polyp burden in some people with FAP. Its use is more limited now because doctors weigh the possible benefit against heart and blood vessel risks, especially with longer treatment.
Aspirin has been studied for colorectal cancer prevention, but it is not a standard main treatment for FAP-related polyps. Some specialists may consider it in certain situations, but the evidence is not strong enough for it to replace proven FAP care.
If desmoid tumors develop, drug treatment may include NSAIDs such as sulindac or celecoxib, and sometimes anti-estrogen medicines such as tamoxifen. These tumors can behave very differently from one person to another, so treatment is often individualized in a specialist center.
Genetic influences
In many living with familial adenomatous polyposis due to 5q22.2 microdeletion, the main reason for the condition is a missing piece of chromosome 5 that removes the APC gene, and sometimes nearby genes too. APC normally helps control cell growth in the lining of the colon, so when one copy is missing, large numbers of polyps can form and the risk of colorectal cancer rises sharply over time. This gene change follows an autosomal dominant inheritance pattern, which means a parent with the microdeletion can pass it to each child with a 1 in 2, or 50%, chance, although some cases happen for the first time in the child. Even with the same gene change, people can have different numbers of polyps and somewhat different health features, especially when the deleted segment is larger and affects neighboring genes. Because the genetic cause is well established in this subtype, relatives may be offered genetic counseling and testing to see who else may be at risk.
Is Familial adenomatous polyposis due to 5q22.2 microdeletion genetic?
Genetics are central to Familial adenomatous polyposis due to 5q22.2 microdeletion, because it is caused by a missing stretch of chromosome 5 that includes APC. This genetic change usually runs in families, though it can also happen for the first time in a child.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most of these variants do not have a direct effect on health and simply reflect natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-understood variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with familial adenomatous polyposis due to 5q22.2 microdeletion, treatment starts with frequent screening and long-term planning, not just taking a pill when symptoms appear. The genetic result shows that a missing piece of chromosome 5 includes the APC gene, which helps doctors decide how closely to watch for new polyps and when preventive surgery may be the safest option. In some families, the larger deletion can also involve nearby genes, so the care team may look for health issues outside the bowel that could affect surgery, anesthesia, or recovery. Genetics is only one factor, but medicines such as sulindac or celecoxib may sometimes reduce the number or size of polyps in familial adenomatous polyposis due to 5q22.2 microdeletion and do not replace regular scopes or surgery when cancer risk is high. There is no routine test that can reliably predict exactly how well those drugs will work for this specific deletion, so doctors usually adjust treatment based on polyp burden, age, symptoms, and side effects. The same genetic finding also helps relatives decide who needs early screening and who can avoid unnecessary testing.
Interactions with other conditions
For many living with familial adenomatous polyposis due to 5q22.2 microdeletion, health concerns may extend beyond colon polyps, so care often involves watching several parts of the body over time. Doctors call it a comorbidity when two conditions occur together. In this condition, there is a higher chance of growths and cancers outside the colon too, including polyps in the stomach or small intestine, desmoid tumors in the abdomen, and a raised risk of thyroid cancer; in children, some families are also counseled about the small but important risk of hepatoblastoma, a liver cancer. If the 5q22.2 microdeletion is larger and affects nearby genes as well as APC, some people may also have developmental or physical differences, which can make care more complex than in classic familial adenomatous polyposis alone. Because the early symptoms of familial adenomatous polyposis may be mild or absent at first, regular screening and coordinated follow-up help doctors spot related problems early and tailor care to the whole picture.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Familial adenomatous polyposis due to 5q22.2 microdeletion?
The main conditions that can look similar are other inherited syndromes that cause many polyps, which are small growths in the lining of the colon and rectum, especially classic or milder familial adenomatous polyposis, MUTYH-associated polyposis, and juvenile polyposis syndrome. Doctors may also consider Lynch syndrome, which can lead to colon cancer at a young age even without large numbers of polyps, and sometimes Peutz-Jeghers syndrome, which can also cause bowel polyps along with other body changes.
History
Across generations, some families noticed a striking pattern: relatives who seemed well in childhood later developed large numbers of growths in the colon, often at a young age, and some went on to develop bowel cancer if the problem was not found early. What we now call familial adenomatous polyposis due to 5q22.2 microdeletion emerged from these family patterns long before doctors understood the biology behind it.
In the late 1800s and early 1900s, physicians began publishing reports of people with hundreds to thousands of colon polyps, along with a very high risk of colorectal cancer. At first, doctors could only describe what they saw during surgery or on tissue examination. Over time, it became clear that this was not a single random event but a condition that could run in families, and that early symptoms of familial adenomatous polyposis might be easy to miss until polyps had already built up. For many living with it, that history helps explain why regular screening became such an important part of care.
As medical science evolved, doctors also recognized that some people had features outside the colon, which helped broaden understanding of the condition. Later, researchers showed that some cases were linked to changes affecting a small section of chromosome 5, including the 5q22.2 region, rather than a change limited to one tiny spot. That mattered because people with this type can have the bowel findings of familial adenomatous polyposis along with other health or developmental features, depending on how much genetic material is missing.
The history of this condition is also the history of prevention. Before modern screening, many families learned about it only after repeated cancers appeared across generations. Today, colonoscopy, genetic testing, and earlier surveillance have changed that picture dramatically. Although the condition remains serious, its story has shifted from late discovery to earlier diagnosis, clearer family counseling, and a much better chance to prevent cancer before it starts.